Psilocybine: End of opioid addiction (fentanyl)?

In the field of research on addiction, a new approach arouses growing interest: the use of psilocybin, the active compound of hallucinogenic mushrooms 🍄, as treatment potential against Opioid dependence 💊. This psychedelic substance, also known as "Psylo", is the subject of a study innovative led by theImperial College London, opening up new perspectives in the fight against this world scourge 🌍, in particular in the face of the opioid crisis that rages in the United States 🇺🇸. Addictions, in particular the Opioid dependence.

Psilocybin: a new approach in the treatment of addictions🍄

What is psilocybin?

Psilocybin is a Psychoactive compound naturally present in some hallucinogenic mushrooms. Long considered only as a recreational substance, psilocybin is today the subject of a renewed interest in the scientific community for its potential therapeutic applications, especially as a psilocybin medication.

The therapeutic potential of psilocybin

Of the recent studies have highlighted the effects promising psilocybin in the treatment various mental health conditions, including depression And anxiety. Its potential in the field of addictions has also been observed, with encouraging results for alcoholism and smoking.

The revolutionary study of the Imperial College London 🔬

Study objectives

The clinical trial led by the Imperial College London aims to explore the efficiency of psilocybin, Combined with psychological support, in the prevention relapses to people who have been dependent to opioids like heroin, the Fentanyl or oxycontin.

This study, described as "first in the United Kingdom", marks an important step in research on psychedelics and addictions.

Clinical trial methodology

The study adopts a rigorous approach, combining the administration of psilocybin with therapeutic support. Participants will be followed for a period of Six months after dosage sessions, thus allowingevaluate changes in their consumption of opioids, their desires, their mental health and their psychological well-being.

The challenges of opioid dependence 💊

The extent of the problem

There Opioid dependence represents a major public health challenge Globally, particularly in the United States where the opioid crisis has taken alarming proportions. L'abusive use drugs like the Fentanyl And Oxycontin contributed to the emergence of what is called "Zombie drug", in reference to Fentanyl effects on its consumers.

Current challenges of treatment

In France, according to health insurance data, nearly 10 million French had a Opioid analgesic prescription In 2015 .. However, the therapeutic options to prevent relapses remain limited. THE Dr David Erritzoe underlines that up to 85% of people relapse within 12 months following the end of their detoxification, highlighting the need crucial new treatments efficient like the psilocybin medicine.

The progress of the clinical trial 🏥

The treatment protocol

Study participants will go to the Imperial College NIHR Clinical Research Center to receive psilocybine therapy. The protocol will also include functional MRI brain imaging, allowing researchers to study the action mechanisms of psilocybin in the brain, in particular in comparison with the effects of fentanyl and other opioids.

Preliminary studies on psilocybin show promising results in the treatment of various forms of addiction.

Its mechanism of action differs from that of opioids, which could make it an interesting alternative for people seeking to free themselves from their dependence. There psilocybin seems to act by temporarily modifying the thought patterns and perceptions, allowing potentially to patients to take a step back on their addiction and develop New perspectives on their lives. This approach could be particularly beneficial to treat the psychological and emotional aspects of dependence on opioids.

The hopes aroused by this research 🔎 

Potential impact on addiction treatment

If this study turns out to be conclusive, it could open the way to a new therapeutic approach For people with dependence on opioids, including those affected by the drug crisis in the United States.

THE Dr Louise Paterson Underlines the potential importance of this study to improve the restoration of a group of seriously underemployed people.

Future perspectives

In case of success, researchers plan to Develop other clinical trials on a larger scale, in order to introduce a new treatment based on Psilocybine drugs For patients and the British national health system (NHS). This approach could revolutionize the management of addictions, offering an alternative to conventional treatments and fentanyl drugs often limited in their effectiveness.

Conclusion🧑‍⚕️

L'Study conducted by Imperial College London on the use of psilocybin in the treatment of dependence on opioids represents a significant advance in research on addictions. By exploring the therapeutic potential of this psychedelic substance, researchers open the way to new approaches In the fight against a major public health problem, especially in the face of the opioid crisis in the United States. If the results prove to be positive, this research could mark a turning point in the management of people suffering from dependence on opioids, offering hope and new perspectives to those who fight against this devastating addiction, including the victims of Zombie drugs.

Faq❓

What is psilocybin?

There psilocybin is the active compound present in some hallucinogenic mushrooms, known as "magic mushrooms" or "Psylo".

How could psilocybin help in the treatment of opioid dependence?

There psilocybin, inasmuch as Psilocybine medication, combined with psychological support, could help prevent relapses by acting on the cerebral mechanisms linked to theaddiction to opioids.

Is this study comparable to the opioid crisis in the United States?

Although the study is conducted in the United Kingdom, its results may have important implications for the crisis of opioids to UNITED STATES, especially in the fight against the abuse of Fentanyl and ofOxycontin.

What are the risks associated with the use of psilocybin in this context?

Participants will be closely monitored to assess the effects on their mental health and tolerance to psilocybin. The study is conducted in a controlled clinical framework to minimize risks, unlike the unsupervised use of drugs like the Fentanyl.

Could psilocybine replace current opioid drugs?

If the study turns out to be conclusive, the psilocybin could offer an alternative to conventional treatments, including Fetanyl drugs, in the management of addiction to opioids.